Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Krabbe disease (globoid cell leukodystrophy)]

N Sakai1, K Inui, S Okada

  • 1Department Environmental Medicine, Osaka Medical Center for Maternal and Child Health.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.

The Journal of pharmacology and experimental therapeutics·2001
Same author

Staged perfusion with an axillary artery graft and deep hypothermia during descending aortic replacement.

The Journal of thoracic and cardiovascular surgery·2001
Same author

EUS-guided one-step drainage of pancreatic pseudocysts: experience in 3 patients.

Gastrointestinal endoscopy·2001
Same author

[Endoscopic ultrasonography for the diagnosis of gastric cancer].

Nihon rinsho. Japanese journal of clinical medicine·2001
Same author

[Bone marrow transplantation of central nervous system diseases].

No to hattatsu = Brain and development·2001
Same author

Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome.

Brain & development·2001
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Krabbe disease, a genetic demyelinating disorder, results from galactocerebrosidase deficiency. Gene therapy shows promise for treating this severe neurological condition in mouse models.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Context:

  • Krabbe disease is an inherited, autosomal recessive demyelinating disorder.
  • It is characterized by severe demyelination and the presence of globoid cells.
  • The disease stems from a deficiency in the lysosomal enzyme galactocerebrosidase.

Purpose:

  • To review the molecular basis of Krabbe disease.
  • To discuss the isolation of cDNA and genome cloning for galactocerebrosidase.
  • To explore the potential of gene therapy for Krabbe disease.

Summary:

  • Krabbe disease involves extreme demyelination in the white matter and peripheral nerves.
  • Key molecular findings include the isolation of human and murine galactocerebrosidase cDNA and gene cloning.

Related Experiment Videos

  • Accumulation of psychosine, not the enzyme's substrates, is observed in affected tissues.
  • Impact:

    • Understanding the molecular genetics provides a foundation for diagnostic and therapeutic strategies.
    • Gene therapy trials in the twitcher mouse model offer hope for treating this progressive demyelinating disease.
    • This research could lead to novel treatments for Krabbe disease and similar lysosomal storage disorders.